Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set
暂无分享,去创建一个
P. Hainaut | D. Evans | J. Garber | S. Savage | J. Schiffman | D. Malkin | K. Nichols | C. Kratz | J. Weitzel | K. Maxwell | C. Freyçon | M. I. Achatz | D. Evans | C. Freycon | D. Evans | D. Evans
[1] J. Garber,et al. Nearly half of TP53 variants are misattributed to Li-Fraumeni syndrome: A clinical evaluation of individuals with TP53 variants detected by hereditary cancer panel assays on blood or saliva. , 2021 .
[2] L. Mirabello,et al. Nearly Half of TP53 Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children's Oncology Group. , 2020, JCO precision oncology.
[3] Shondra M. Pruett-Miller,et al. XAF1 as a modifier of p53 function and cancer susceptibility , 2020, Science Advances.
[4] E. Schröck,et al. Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes , 2020, European Journal of Human Genetics.
[5] A. Spurdle,et al. Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants , 2020, medRxiv.
[6] R. Gelman,et al. Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing , 2018, Journal of the National Cancer Institute.
[7] Roland Eils,et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort , 2018, The Lancet. Oncology.
[8] Pierre Hainaut,et al. Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li–Fraumeni syndrome , 2018, Current opinion in oncology.
[9] P. Hainaut,et al. Ancestry of the Brazilian TP53 c.1010G>A (p.Arg337His, R337H) Founder Mutation: Clues from Haplotyping of Short Tandem Repeats on Chromosome 17p , 2015, PloS one.
[10] C. Bonaïti‐pellié,et al. Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Robert Huether,et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia , 2013, Nature Genetics.
[12] C. Bonaïti‐pellié,et al. Sensitivity and predictive value of criteria for p53germline mutation screening , 2001, Journal of medical genetics.
[13] W. Blattner,et al. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.
[14] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[15] W. Blattner,et al. A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.
[16] J. Fraumeni,et al. Prospective study of a family cancer syndrome. , 1982, JAMA.
[17] J. Fraumeni,et al. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. , 1969, Journal of the National Cancer Institute.
[18] J. Fraumeni,et al. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.